Paya Carlos V 4
4 · Vaxcyte, Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Paya Carlos V
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-06+7,250→ 7,250 totalExercise: $72.51Exp: 2034-06-05→ Common Stock (7,250 underlying) - Award
Common Stock
2024-06-06+1,550→ 4,050 total
Holdings
- 3,125(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- [F2]Shares are held directly by a trust for the sole benefit of the Reporting Person.
- [F3]The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.